[1. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840-844.10.1001/jama.1994.03510350050036]Search in Google Scholar
[2. Brandes A, Smit MD, Nguyen BO, Rienstra M, Van Gelder IC. Risk factor management in atrial fibrillation. Arrhythm Electrophysiol Rev. 2018;7:118-127.10.15420/aer.2018.18.2]Search in Google Scholar
[3. Lau DH, Mackenzie L, Kelly DJ, et al. Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model. Heart Rhythm. 2010;7:396-404.10.1016/j.hrthm.2009.11.031]Search in Google Scholar
[4. Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol. 2000;35:1669-1677.10.1016/S0735-1097(00)00611-2]Search in Google Scholar
[5. Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation. 2000;101:2678-2681.10.1161/01.CIR.101.23.2678]Search in Google Scholar
[6. Okazaki H, Minamino T, Tsukamoto O, et al. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertens Res. 2006;29:277-284.10.1291/hypres.29.27716778335]Search in Google Scholar
[7. Scridon A, Gallet C, Arisha MM, et al. Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. Am J Physiol Heart Circ Physiol. 2012;303:H386-H392.10.1152/ajpheart.00004.201222661510]Search in Google Scholar
[8. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920-2925.10.1161/01.CIR.0000072767.89944.6E12771006]Search in Google Scholar
[9. Lee KW, Everett TH 4th, Rahmutula D, et al. Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation. 2006;114:1703-1712.10.1161/CIRCULATIONAHA.106.624320212910317030685]Search in Google Scholar
[10. Yeh YH, Wakili R, Qi XY, et al. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol. 2008;1:93-102.10.1161/CIRCEP.107.75478819808399]Search in Google Scholar
[11. Li D, Melnyk P, Feng J, et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation. 2000;101:2631-2638.10.1161/01.CIR.101.22.2631]Search in Google Scholar
[12. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and independent pathways. Cardiovasc Res. 2003;60:315-325.10.1016/j.cardiores.2003.08.014]Search in Google Scholar
[13. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105:2753-2759.10.1161/01.CIR.0000018443.44005.D8]Search in Google Scholar
[14. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 2000; 101:2612-2617.10.1161/01.CIR.101.22.2612]Search in Google Scholar
[15. Scridon A, Dobreanu D, Chevalier P, Șerban RC. Inflammation, a link between obesity and atrial fibrillation. Inflamm Res. 2015;64:383-393.10.1007/s00011-015-0827-8]Search in Google Scholar
[16. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983;106:389–396.10.1016/0002-8703(83)90208-9]Search in Google Scholar
[17. Lammers WJ, Kirchhof C, Bonke FI, Allessie MA. Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol. 1992;262:H47-H55.10.1152/ajpheart.1992.262.1.H471733321]Search in Google Scholar
[18. Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107:1930-1936.10.1161/01.CIR.0000058743.15215.0312668526]Search in Google Scholar
[19. Şerban RC, Scridon A. Data Linking diabetes mellitus and atrial fibrillation-how strong is the evidence? From epidemiology and pathophysiology to therapeutic implications. Can J Cardiol. 2018;34:1492-1502.10.1016/j.cjca.2018.08.01830404752]Search in Google Scholar
[20. Rutter MK, Parise H, Benjamin EJ, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation. 2003;107:448-454.10.1161/01.CIR.0000045671.62860.9812551870]Search in Google Scholar
[21. Kato T, Yamashita T, Sekiguchi A, et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol. 2006;17:890-894.10.1111/j.1540-8167.2006.00528.x]Search in Google Scholar
[22. Chao TF, Suenari K, Chang SL, et al. Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. Am J Cardiol. 2010;106:1615-1620.10.1016/j.amjcard.2010.07.03821094363]Search in Google Scholar
[23. Otake H, Suzuki H, Honda T, Maruyama Y. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J. 2009;50:627-641.10.1536/ihj.50.62719809211]Search in Google Scholar
[24. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471-2477.10.1001/jama.292.20.247115562125]Search in Google Scholar
[25. Pathak RK, Middeldorp ME, Meredith M, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: A long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65:2159-2169.10.1016/j.jacc.2015.03.00225792361]Search in Google Scholar
[26. Abed HS, Samuel CS, Lau DH, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10:90-100.10.1016/j.hrthm.2012.08.04323063864]Search in Google Scholar
[27. Munger TM, Dong YX, Masaki M, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60:851-860.10.1016/j.jacc.2012.03.04222726633]Search in Google Scholar
[28. Lin YK, Chen YC, Chen JH, Chen SA, Chen YJ. Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation. Basic Res Cardiol. 2012;107:293-303.10.1007/s00395-012-0293-122886089]Search in Google Scholar
[29. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910-916.10.1164/rccm.200509-1442OC266290916424443]Search in Google Scholar
[30. Orban M, Bruce CJ, Pressman GS, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol. 2008;102:1557-1561.10.1016/j.amjcard.2008.07.050263821019026314]Search in Google Scholar
[31. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-1904.10.1172/JCI1182351858267560081]Search in Google Scholar
[32. Hatipoğlu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration. 2003;70:665-671.10.1159/00007521814732803]Search in Google Scholar
[33. Stevenson IH, Roberts-Thomson KC, Kistler PM, et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 2010;7:1263-1270.10.1016/j.hrthm.2010.03.02020338265]Search in Google Scholar
[34. Linz D, Schotten U, Neuberger HR, Böhm M, Wirth K. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm. 2011;8:1436-1443.10.1016/j.hrthm.2011.03.05321457790]Search in Google Scholar
[35. Qureshi WT, Alirhayim Z, Blaha MJ, et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) Project. Circulation. 2015;131:1827-1834.10.1161/CIRCULATIONAHA.114.01483325904645]Search in Google Scholar
[36. Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009;11:1156-1159.10.1093/europace/eup19719633305]Search in Google Scholar
[37. Thorp AA, Owen N, Neuhaus M, Dunstan DW. Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996-2011. Am J Prev Med. 2011;41:207-215.10.1016/j.amepre.2011.05.00421767729]Search in Google Scholar
[38. Allison MA, Jensky NE, Marshall SJ, Bertoni AG, Cushman M. Sedentary behavior and adiposity-associated inflammation: the Multi-Ethnic Study of Atherosclerosis. Am J Prev Med. 2012;42:8-13.10.1016/j.amepre.2011.09.023324467622176840]Search in Google Scholar
[39. Mueller PJ. Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity. Clin Exp Pharmacol Physiol. 2007;34:377-384.10.1111/j.1440-1681.2007.04590.x17324153]Search in Google Scholar
[40. Lindsay MM, Dunn FG. Biochemical evidence of myocardial fibrosis in veteran endurance athletes. Br J Sports Med. 2007;41:447-452.10.1136/bjsm.2006.031534246535817311809]Search in Google Scholar
[41. Guasch E, Benito B, Qi X, et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol. 2013;62:68-77.10.1016/j.jacc.2013.01.09123583240]Search in Google Scholar
[42. Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2009;11:11-17.10.1093/europace/eun289263865518988654]Search in Google Scholar
[43. Shang W, Li L, Huang S, et al. Chronic kidney disease and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies. PLoS One. 2016;11:e0155581.10.1371/journal.pone.0155581486673127175779]Search in Google Scholar
[44. Fukunaga N, Takahashi N, Hagiwara S, et al. Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress. Heart Rhythm. 9:2023-2031.10.1016/j.hrthm.2012.08.01922906534]Search in Google Scholar
[45. Beretta-Piccoli C, Weidmann P, Schiffl H, Cottier C, Reubi FC. Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease. Kidney Int. 1982;22:297-303.10.1038/ki.1982.1697176332]Search in Google Scholar
[46. Konecny T, Park JY, Somers KR, et al. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol. 2014;114:272-277.10.1016/j.amjcard.2014.04.03024878126]Search in Google Scholar
[47. Hubatsch M, Kikeli P, Preg Z, et al. Risk factor for complex chronic comorbidities, a retrospective case-control study. Acta Medica Marisiensis. 2011;57:209-213.]Search in Google Scholar
[48. Johnson LS, Juhlin T, Engström G, Nilsson PM. Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmo Preventive Project. Europace. 2014;16:182-188.10.1093/europace/eut25523960091]Search in Google Scholar
[49. Acar G, Kahraman H, Akkoyun M, et al. Evaluation of atrial electromechanical delay and its relationship to inflammation and oxidative stress in patients with chronic obstructive pulmonary disease. Echocardiography. 2014;31:579-585.10.1111/echo.1244224372655]Search in Google Scholar
[50. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59:574-580.10.1136/thx.2003.019588174707015223864]Search in Google Scholar
[51. Heeringa J, Kors JA, Hofman A, van Rooij FJ, Witteman JC. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J. 2008;156:1163-1169.10.1016/j.ahj.2008.08.00319033014]Search in Google Scholar
[52. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol. 2004;43:1731-1737.10.1016/j.jacc.2003.12.04715145091]Search in Google Scholar
[53. Shan H, Zhang Y, Lu Y, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res. 2009;83:465-472.10.1093/cvr/cvp130]Search in Google Scholar
[54. Laustiola KE, Kotamaki M, Lassila R, Kallioniemi OP, Manninen V. Cigarette smoking alters sympathoadrenal regulation by decreasing the density of beta 2-adrenoceptors. A study of monitored smoking cessation. J Cardiovasc Pharmacol. 1991;17:923-928.10.1097/00005344-199106000-00010]Search in Google Scholar
[55. Wang H, Yang B, Zhang L, Xu D, Wang Z. Direct block of inward rectifier potassium channels by nicotine. Toxicol Appl Pharmacol. 2000;164:97-101.10.1006/taap.2000.8896]Search in Google Scholar
[56. Gallagher C, Hendriks JML, Elliott AD, et al. Alcohol and incident atrial fibrillation – A systematic review and meta-analysis. Int J Cardiol. 2017;246:46-52.10.1016/j.ijcard.2017.05.133]Search in Google Scholar
[57. Gallardo-Carpentier A, Aileru AA, Carpentier RG. Arrhythmogenic and antiarrhythmic actions of substances of abuse: effects on triggered activity. J Electrocardiol. 1997;30:137-142.10.1016/S0022-0736(97)80022-2]Search in Google Scholar
[58. Qiao Y, Shi R, Hou B, et al. Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation. J Am Heart Assoc. 2015;4:e002349.10.1161/JAHA.115.002349]Search in Google Scholar
[59. Laszlo R, Eick C, Schwiebert M, et al. Alcohol-induced electrical remodeling: effects of sustained short-term ethanol infusion on ion currents in rabbit atrium. Alcohol Clin Exp Res. 2009;33:1697-1703.10.1111/j.1530-0277.2009.01006.x]Search in Google Scholar
[60. Gould L, Reddy CV, Becker W, Oh KC, Kim SG. Electrophysiologic properties of alcohol in man. J Electrocardiol. 1978;11:219-226.10.1016/S0022-0736(78)80120-4]Search in Google Scholar
[61. Cardy MA, Donnerstein RL, Kelly LF, Bittner NH, Palombo GM, Goldberg SJ. Acute effects of ethanol ingestion on signal-averaged electrocardiograms. Am J Cardiol. 1996;77:1356-1357.10.1016/S0002-9149(96)00205-6]Search in Google Scholar
[62. Süfke S, Fiedler S, Djonlagiç H, Kibbel T. Continuous analysis of heart rate variability for examination of cardiac autonomic nervous system after alcohol intoxication. Med Klin (Munich.) 2009;104:511-519.10.1007/s00063-009-1110-y]Search in Google Scholar
[63. Shao Q, Liu T, Korantzopoulos P, Zhang Z, Zhao J, Li G. Association between air pollution and development of atrial fibrillation: A meta-analysis of observational studies. Heart Lung. 2016;45:557-562.10.1016/j.hrtlng.2016.08.00127590407]Search in Google Scholar
[64. Peters A, Fröhlich M, Döring A, et al. Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J. 2001;22:1198-1204.10.1053/euhj.2000.248311440492]Search in Google Scholar
[65. Schwartz J, Litonjua A, Suh H, et al. Traffic related pollution and heart rate variability in a panel of elderly subjects. Thorax. 2005;60:455-461.10.1136/thx.2004.024836174741915923244]Search in Google Scholar
[66. Liao D, Shaffer ML, He F, et al. Fine particulate air pollution is associated with higher vulnerability to atrial fibrillation-the APACR study. J Toxicol Environ Health A. 2011;74:693-705.10.1080/15287394.2011.556056308284921480044]Search in Google Scholar
[67. Rienstra M, Hobbelt AH, Alings M, et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J. 2018;39:2987-2996.10.1093/eurheartj/ehx73929401239]Search in Google Scholar